Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay

Transfusion

Volumn 51, Issue 1, 2011, Pages 166-174

  Makar, Robert S ^a,b   Saidman, Susan L ^a,b   Stowell, Christopher P ^a,b   Lee, Hang ^a,b   Powers, Amy ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

ANTIBODY SCREENING; APHERESIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CYTOMETRIC MICROBEAD ASSAY; FEMALE; HUMAN; NORMAL HUMAN; PREDICTIVE VALUE; PREGNANCY; SCREENING TEST;

BLOOD DONORS; DONOR SELECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MICROSPHERES;

EID: 78651351723     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02771.x     Document Type: Article

References (21)

1. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2007. Rockville (MD): CBER Office of Compliance and Biologics Quality; 2008.
2. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2008. Rockville (MD): CBER Office of Compliance and Biologics Quality; 2009.
3. Bux J,. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89: 1-10.
4. Silliman CC, Ambruso DR, Boshkov LK,. Transfusion-related acute lung injury. Blood 2005; 105: 2266-73.
5. Bux J, Sachs UJ,. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-99.
6. Middelburg RA, van Stein D, Briet E, van der Bom JG,. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008; 48: 2167-76.
7. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM, Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-52.
8. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, Dodd RY, Benjamin RJ,. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007; 47: 599-607.
9. Transfusion-related acute lung injury. Association Bulletin #06-07. Bethesda (MD): AABB; 2006.
10. Eder AF, Herron RM, Strupp A, Dy B, White J, Notari EP, Dodd RY, Benjamin RJ,. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion [Internet] 2010. [cited 2010 May 11]. Available from
11. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB,. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-35.
12. Clarifications to recommendations to reduce the risk of TRALI. Association Bulletin #07-03. Bethesda (MD): AABB; 2007.
13. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS,. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48: 2549-58.
14. Delmonico FL, Fuller A, Cosimi AB, Tolkoff-Rubin N, Russell PS, Rodey GE, Fuller TC,. New approaches to donor crossmatching and successful transplantation of highly sensitized patients. Transplantation 1983; 36: 629-33.
15. Whitaker BI, Green J, King MR, Leibeg LL, Mathew SM, Schlumpf KS, Schreiber GB,. The 2007 Nationwide Blood Collection and Utilization Survey. Washington, DC: United States Department of Health and Human Services; 2007.
16. Carrick DM, Endres RO, Kleinman SH, Sun Y, Wright DJ, Norris PJ, Steele WR, Busch MP,. Strength of signal on a HLA screening assay positively correlates with breadth of specific HLA antigen reactivity. Transfusion 2009; 49 Suppl: 7A.
17. Kakaiya RM, Triulzi DJ, Wright DJ, Steele WR, Kleinman SH, Busch MP, Norris PJ, Hillyer CD, Gottschall JL, Rios JA, Carey P, Glynn SA,. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010; 50: 1328-34.
18. van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A,. HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 2003; 43: 765-71.
19. Norris PJ, Lee JH, Carrick DM, Gottschall JL, Lebedeva M, de Castro BR, Kleinman SH, Busch MP,. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion 2009; 49: 243-51.
20. ISBT Working Party on Granulocyte Immunobiology, Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, Macek M, Muniz-Diaz E, Porcelijn L, Reil A, Sachs U, Schuller R, Tsuno N, Uhrynowska M, Urbaniak S, Valentin N, Wikman A, Zupanska B,. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009; 96: 266-9.
21. Reil A, Keller-Stanislawski B, Gunay S, Bux J,. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008; 95: 313-7.